Skip to main content
Skip to main content
Home
Company
About Us
Executive Team
Board of Directors
Scientific & Clinical Advisors
Partners
Pipeline
Technology
EQ504
EQ302
Publications
Presentations
Investors
Investor Overview
Stock Information
Stock Chart
Analyst Coverage
Press Releases
Events & Presentations
Email Alerts & Contacts
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Careers
Contact Us
Search query
Presentation Details
Back
AhR Modulation by EQ504 Restores Immune Balance by Suppressing Pathogenic Th17/M1 Responses While Enhancing Regulatory Pathways<span>Jeanette Ampudia, et. al.</span><span> 7th Internation AHR Conference </span><span>2026</span>
09/29/2026
Download this Press Release
PDF Format (opens in new window)
Jeanette Ampudia, et. al.
Conference:
7th Internation AHR Conference
Year:
2026
